Omisafe 250mg Injection
Marketer
Innovative Pharmaceuticals
Salt Composition
Ceftriaxone (250mg)
Overview Omisafe 250mg Injection
Cefixime 250mg injection, a cephalosporin antibiotic, combats bacterial infections throughout the body. Its uses encompass infections affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, blood, and heart. Prophylactically, it may prevent surgical site infections. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined individually. Consistent, evenly spaced doses, as directed, are crucial; premature cessation risks relapse or infection exacerbation. Common side effects include diarrhea, skin rashes, altered liver function test results, and blood cell count abnormalities (e.g., eosinophilia, leukopenia, thrombocytopenia). Transient injection site redness or pain may occur. While usually mild, persistent or bothersome side effects warrant medical attention. Prior to use, disclose any antibiotic allergies, kidney or liver conditions, and all other medications to your doctor, as interactions are possible.
Primary Ingredients of Omisafe 250mg Injection
There is no text provided to rephrase.
Uses of Omisafe 250mg Injection
Managing bacterial infections
Major Benefits of Omisafe 250mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Omisafe 250mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Omisafe 250mg Injection:
Administering this medication will be performed by your physician or registered nurse; self-medication is strictly prohibited.
How Omisafe 250mg Injection works:
The antibiotic injection, Omisafe 250mg, eradicates bacteria by disrupting their cell wall synthesis, a crucial process for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Omisafe 250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Omisafe, 250mg, presents minimal to no documented risk to the fetus during gestation, according to the majority of research.
Breast feedingCAUTION
Administering Omisafe 250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Omisafe 250mg Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or vertigo. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
The 250mg Omisafe injection can be administered to patients with renal impairment without altering the dosage. Nevertheless, disclosure of any pre-existing kidney conditions to your physician is advisable.
LiverCAUTION
The administration of Omisafe 250mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Omisafe 250mg Injection dosage is generally not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Omisafe 250mg Injection :
Should you forget a scheduled dose of the Omisafe 250mg Injection, seek advice from your physician.
Facts to Know About Omisafe 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently